| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc788dc22d2fff9e51fb63ddf3976055 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-571 |
| filingDate |
2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_637e7728be2e94015774f22ecd745e39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec9c4b8a70402e462ca555902a5cf650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7888226a99fdbd38bcbe4f260ec28e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf7be28e487116312f4bc02d377b82cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd47dbbe5444626a1a5ae8df00a5582 |
| publicationDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2908415-A1 |
| titleOfInvention |
Anti alpha-gal igm monoclonal antibody capable of recognising cells infected with the human papillomavirus, and method for obtaining same |
| abstract |
The invention relates to the development of an Igm-type monoclonal antibody (AcMo) directed against a-Gal present in the membrane of cells infected with the human papillomavirus and to a diagnosis technique using labelling with fluorophore of protoporphyrin IX (PpIX). The invention also relates to the use of same as a method that is complementary to existing methods, offering increased specificity and sensitivity, for the in situ and in vivo diagnosis and treatment of patients with HPV. |
| priorityDate |
2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |